🇰🇷 Dynacirc in South Korea

Dynacirc (ISRADIPINE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Dynacirc in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in South Korea

Frequently asked questions

Is Dynacirc approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Dynacirc in South Korea?

Smithkline Beecham is the originator. The local marketing authorisation holder may differ — check the official source linked above.